- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 14, 2026 | 73.46M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 73.46M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 73.46M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 72.8M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 72.41M sh |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$7.22M |
| Operating Cash Flow restated | Q3 2026 · Mar 31, 2025 | −$7.82M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | −$38.56M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$27.28M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | −$35.19M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$31.77M |
| Stockholders Equity restated | Q3 2026 · Mar 31, 2025 | −$29.45M |
| Stockholders Equity restated | Q3 2026 · Dec 31, 2024 | −$24.39M |
| Stockholders Equity restated | Q3 2026 · Sep 30, 2024 | −$18.95M |
| Stockholders Equity restated | Q3 2026 · Jun 30, 2024 | −$13.66M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $42.32M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $35.52M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $42.32M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $35.52M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $2.79M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $2.86M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $3.77M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $3.75M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.16 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.10 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.07 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$0.23 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.16 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.10 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.07 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$0.23 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $503K |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $1.9M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $456K |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $2.1M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$11.42M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$7.14M |
| Net Income | Q3 2026 · Dec 31, 2025 | $7.77M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$3.48M |
| Net Income restated | Q3 2026 · Mar 31, 2025 | −$5.15M |
| Net Income restated | Q3 2026 · Mar 31, 2025 | −$16.42M |
| Net Income restated | Q3 2026 · Dec 31, 2024 | −$5.93M |
| Net Income restated | Q3 2026 · Sep 30, 2024 | −$5.34M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$2.41M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$7.67M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$1.97M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$13.17M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | −$313K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | −$696K |
| Gross Profit restated | Q3 2026 · Mar 31, 2025 | −$142K |
| Gross Profit restated | Q3 2026 · Mar 31, 2025 | −$329K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $415K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $874K |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $143K |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $347K |
| Revenue | Q3 2026 · Mar 31, 2026 | $102K |
| Revenue | Q3 2026 · Mar 31, 2026 | $178K |
| Revenue restated | Q3 2026 · Mar 31, 2025 | $1K |
| Revenue restated | Q3 2026 · Mar 31, 2025 | $18K |